INTRODUCTION {#sec1}
============

Recurrent pregnancy loss (RPL), or consecutive pregnancy loss, is a disease characterized by two, three or more failed pregnancies. It affects approximately 1--2% of reproductive women and is more common in women older than 40 years. RPL must be distinguished from sporadic pregnancy loss, or non-consecutive pregnancy loss, which occurs randomly in women's reproductive years in approximately 15% of pregnancies. While many cases are caused by several potential risk factors, including uterine anomalies, antiphospholipid syndrome, endocrinological abnormalities, and chromosomal abnormalities, up to 50% of RPL cases have no evident cause which requires further testing procedures to identify the underlying cause \[[@ref1], [@ref2]\].

Endometrial polyps (EP) are localized hyperplastic overgrowths of endometrium that contain both endometrial glands and stroma. EP are one of the intrauterine abnormalities that may be seen during the infertility workup and are common among women with unexplained infertility \[[@ref3]\].

CASE REPORT {#sec2}
===========

A 44-year-old woman came to the clinic complaining of secondary infertility for about 10 years in which she had three gestations that were all ended with spontaneous abortions within about 1 month of gestation. The abortions were managed expectantly by her previous physician and stated as complete miscarriages depending on bleeding cease and ultrasound images. She had a normal regular menstrual cycle and her body mass index (BMI) was 21.8 with no other complaints or diseases and no medications. The patient had previously undergone a hysterosalpingography (HSG) which showed no abnormality. We checked hormones levels in the blood and they were all within normal range ([Table 1](#TB1){ref-type="table"}). We did a transvaginal ultrasound (TVUS) for the uterus and found no abnormality. Eventually, we did a hysteroscopy and found a 2.5 × 1.5 cm polyp-like mass in the fundus of the uterus ([Fig. 1](#f1){ref-type="fig"}). The mass was excised and sent to pathology which revealed an endometrial stroma showing severe decidualization with a lot of gestational villi showing fibrosis and hyaline degeneration, features of old gestational product death, with no glands crowding or cellular atypia ([Fig. 2](#f2){ref-type="fig"}). The duration in which these tissues were formed and then underwent fibrosis and hyaline degeneration was estimated to be a few years depending on the existing dystrophic calcification in it. The patient's partner underwent semen analysis, concerning number, shape of the sperm and its motility and the tests were normal. Afterwards, the patient underwent IVF with no success in conceiving.

###### 

Laboratory tests on admission

  Variable                     Result                    Normal range
  ---------------------------- ------------------------- ---------------------------
  TSH                          1 mIU/l                   0.4--4.0 mIU/l
  PRL                          27 ng/ml                  Non-pregnant: 2--29 ng/ml
  After cabergoline: 2 ng/ml   Pregnant: 10--209 ng/ml   
  E2 (estradiol)               64 pg/ml                  15--350 pg/ml
  FSH                          4 IU/l                    4.5--21.5 IU/l

![Hysteroscopy showing a polyp-like mass in the uterine cavity.](omaa038f1){#f1}

![Photomicrograph (×20; hematoxylin-eosin \[H-E\] stain) of Fibrotic Abortion Tissue (Old Gestational Product Death). No Hyperplasia; No hydatidiform mole; No choriocarcinoma. Arrows pointing to fibrotic gestational villi (chronic villi).](omaa038f2){#f2}

DISCUSSION {#sec3}
==========

Increased endogenous oestrogen and exogenous oestrogen administration, like tamoxifen, are risk factors for the formation of EP. EP can be single or multiple, sessile or pedunculated and measured in millimetres to centimetres. 95% of EP are benign. The risk of developing malignancy appears to be associated with the following: menopause, big size (\>1.5 cm) and abnormal bleeding \[[@ref3], [@ref4]\].

Some EP are identified during the evaluation of abnormal bleeding, but many polyps are asymptomatic and only discovered during infertility evaluation \[[@ref3]\].

Although there is no uniform approach in assessing RPL, TVUS is considered the first-line imaging test to investigate any abnormality in the reproductive organs due to its low cost and convenience. Its sensitivity in detecting EP is 83.3% \[[@ref5]\].

HSG is low-invasive radiography that uses a transcervical injection of iodinated contrast with concurrent fluoroscopy to reveal any occlusion in any part of the female reproductive cavities. However, HSG is less sensitive for the diagnosis of intrauterine pathology which in the case of EP has approximately a sensitivity of 50% compared with sonohysterography with a sensitivity up to 90% \[[@ref6]\].

Hysteroscopy remains the gold standard for evaluation of the uterine cavity. On hysteroscopy, EP are found in up to 25% of women with unexplained infertility \[[@ref3], [@ref5]\].

Clinical suspicion of EP occurs during hysteroscopy, but the confirmation requires microscopic examination. Many pathological findings distinguish EP from the normal endometrium. In EP, the stroma is dense fibrous tissue; endometrial glands have parallel arrangement long axis to the surface epithelium; glands are often dilated, spaced closely together and have unusual shapes; and stromal blood vessels are thick-walled. Most EP have immature endometrium, which does not respond to hormones. Cystic hyperplasia is the dominant appearance of these polyps. They do not undergo the decidual changes and menstrual shedding. Less EP may be composed of functional endometrium, which changes histologically during the menstrual cycle \[[@ref4]\]. In the case we present, the polyp did not contain glands crowding but endometrial stroma only, with a lot of fibrotic gestational villi.

EP have been associated with an increased probability of abnormal endometrial molecular expressions thought to impair implantation and early embryo development. Thus, EP have an adverse effect on endometrial receptivity. Polyp resection, polypectomy, is generally recommended for infertile women prior to fertility treatments as hysteroscopy with polypectomy enhances chances for conception \[[@ref7]\].

IVF technology is a promising solution for those who cannot conceive naturally. Many female factors play a role in determining whether the procedure will accomplish a successful gestation or not. Taking this fact into consideration, IVF has a probability to fail due to an impairment in one of those factors \[[@ref8]\].

In our case, aside from the gestational product polyp, we could not identify the underlying cause of infertility, leaving it in the 50% of RPL cases with an unidentified cause \[[@ref1]\].

A condition called missed abortion is when ultrasound (\<14WG) shows no growth of intrauterine sac/embryo and/or loss of fetal heart activity of a confirmed pregnancy. This is close to what we present here, but missed abortion differs in causing amenorrhea \[[@ref9]\], whereas in this case, the patient menstrual cycle was regular and normal in the presence of the polyp.

Another similar condition is retained products of conception which is described in the medical literature as a common problem after vaginal or caesarean delivery causing prolonged postpartum haemorrhage, fever and abdominal pain \[[@ref10]\]. In our case, the conception products were not retained after a miscarriage or delivery, and also, they did not cause any symptoms indicating gestation after conceiving nor any symptoms indicating the death of the gestational products.

The asymptomatic endometrial polyp filled with fibrotic gestational villi without a prior miscarriage is an unprecedented case in the medical literature that may be added to the list of other findings that could present on infertility investigation. Therefore, take it into consideration while investigating for infertility-related EP. Also, emphasize the importance of pathological examination in infertility investigation which enables us, besides the clinical history, to distinguish the case from other findings that might present in an EP which can cause gestational impairment and differ in the treatment method.
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